Clinical Trial Update: Avatrombopag Combined With All-trans Retinoic Acid in the Treatment of Primary Immune Thrombocytopenia [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial is evaluating the combination of avatrombopag with all-trans retinoic acid for primary immune thrombocytopenia in Phase 2/Phase 3 and is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• All-trans Retinoic Acid (all-trans retinoic acid)
• DOPTELET (avatrombopag)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: ITP - Immune Thrombocytopenia | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING